Growing community of inventors

Sunnyvale, CA, United States of America

Wendy Luo

Average Co-Inventor Count = 3.47

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 26

Wendy LuoRitu Lal (8 patents)Wendy LuoAdam Galan (8 patents)Wendy LuoLiang Zeng Yan (3 patents)Wendy LuoKent K Grindstaff (3 patents)Wendy LuoRemi Magnan (3 patents)Wendy LuoKenneth C Cundy (3 patents)Wendy LuoYongjin Yao (3 patents)Wendy LuoWendy Luo (11 patents)Ritu LalRitu Lal (12 patents)Adam GalanAdam Galan (12 patents)Liang Zeng YanLiang Zeng Yan (11 patents)Kent K GrindstaffKent K Grindstaff (4 patents)Remi MagnanRemi Magnan (4 patents)Kenneth C CundyKenneth C Cundy (4 patents)Yongjin YaoYongjin Yao (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Gen1e Lifesciences Inc. (7 from 8 patents)

2. Cohbar, Inc. (3 from 4 patents)

3. Genie Lifesciences Inc. (1 from 2 patents)


11 patents:

1. 12331024 - Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors

2. 12269792 - Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate

3. 11976049 - Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors

4. 11926635 - P38α mitogen-activated protein kinase inhibitors

5. 11753445 - Therapeutic peptides

6. 11555020 - Substituted naphthyl p38α mitogen-activated protein kinase inhibitors

7. 11440918 - p38α mitogen-activated protein kinase inhibitors

8. 11390581 - Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate

9. 11332497 - Therapeutic peptides

10. 11286260 - P38α mitogen-activated protein kinase inhibitors

11. 11111271 - Therapeutic peptides

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
9/20/2025
Loading…